The effect of anticoagulant adjuvant anti-tumor therapy depends on the cancer type and
stage and on the type of the used anticoagulant drug. A striking response rate was …

This overview of the coagulation biology of cancer is intended primarily for those unfamiliar
with the link between the coagulation mechanism and neoplasia. Because the literature on …

Anaphylaxis or angioedema in response to recombinant tissue-type plasminogen activator
or urokinase have been reported in only a few isolated cases. Both agents are endogenous …

Clinical trials of drugs that influence coagulation and fibrinolysis pathways have been
undertaken in patients with malignancy because these pathways are capable of influencing …

Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …

This text provides comprehensive and timely coverage of the current knowledge of cancer-
associated thrombosis, its pathogenesis, clinical features, prevention, and therapy. It …

It is a long-known principle that tumour cells tend to exploit the host's physiologic systems in
order to get support in terms of, for example, nutrition, growth or metastasis. One of these …

The blood coagulation mechanism in general and the plasminogen system in particular
contribute to malignant growth and dissemination in complex ways. This article reviews the …

The Subcommittee on Hemostasis and Malignancy of the Scientific and Standardization
Committee determined at its meeting of July 8, L992, to update the registry of clinical trials of …

they review extensively drug therapy (and briefly surgery) for pain relief. Patients with severe
cancer pain often have spinal lesions that destroy bone and compress the spinal cord, or …